- Home
- RAMP vs RCKT Comparison
RAMP vs RCKT Comparison
Compare RAMP & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAMP | RCKT |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 340.9M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAMP | RCKT |
|---|---|---|
| Price | $29.84 | $3.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $40.17 | $29.12 |
| AVG Volume (30 Days) | 557.4K | ★ 2.3M |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1315.78 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $778,787,000.00 | N/A |
| Revenue This Year | $11.00 | N/A |
| Revenue Next Year | $9.18 | N/A |
| P/E Ratio | $51.87 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $22.82 | $2.19 |
| 52 Week High | $36.08 | $13.50 |
Technical Indicators
Market Signals| Indicator | RAMP | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 55.17 | 53.50 |
| Support Level | $28.98 | $3.30 |
| Resistance Level | $30.63 | $3.65 |
| Average True Range (ATR) | 0.76 | 0.19 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 62.81 | 66.67 |
Price Performance
Historical ComparisonAbout RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.